Chimeric Therapeutics Raises $7.37m for licence agreements
- Chimeric Therapeutics (CHM) successfully completes its institutional entitlement offer and raises $7.37 million
- This institutional entitlement offer forms part of Chimeric’s $18.1 million entitlement offer with the money to be used to fund Chimeric’s licence and sponsored agreements
- More than 43.33 million fully-paid ordinary shares were issued under the institutional component at 17 cents
- Chimeric will now undertake the retail entitlement offer which is expected to raise up to $10.75 million
- Shares in Chimeric were down 11.9 per cent at 17 cents
